Fig. 1 · Structure
Documents & Downloads
CVT-2738
Ranolazine Metabolite
CVT-2738 is an orally active metabolite of Ranolazine, primarily targeting cardiac pathways. This compound demonstrates a protective effect against Isoprenaline-induced myocardial ischemia in murine models. CVT-2738 is suitable for research applications focused on myocardial ischemia and related cardiovascular studies.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| CAS Number | 5294-61-1 |
| Applications | Ranolazine Metabolite |
| Formula | C14H21N3O |
| Molecular Weight | 247.34 |
| Synonyms | RS-94287 |
| SMILES | O=C(NC1=C(C)C=CC=C1C)CN2CCNCC2 |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.